Ang-(1-7) in animal models of stroke
Type of stroke induced | Animal model | Main finding | References |
---|---|---|---|
Ischemic stroke | Endothelin1-induced middle cerebral artery occlusion (MCAO) | - Ang-(1-7) central administration reduced the brain infarct size and neurological alteration 72 h after the insult.- Beneficial actions of Ang-(1-7) were mediated by MasR. | Mecca et al., 2011 [109] |
Permanent middle cerebral artery occlusion (pMCAO) | - Intracerebral infusion of Ang-(1-7) decreased infarct volume and improved neurological alteration after 24 h following the insult.- Ang-(1-7) had an antioxidant effect, inhibited NF-κB activity and decreased pro-inflammatory cytokines and COX-2 in the peri-infarct areas.- Beneficial actions of Ang-(1-7) were mediated by MasR. | Jiang et al., 2012 [93] | |
- Intracerebral infusion of Ang-(1-7) for 4 weeks reduced infarct size and neurological alteration after pMCAO.- Ang-(1-7) increased cerebral capillary density via stimulation of endothelial cell proliferation and eNOS activation.- Beneficial effects of Ang-(1-7) were mediated by MasR. | Jiang et al., 2014 [126] | ||
- Ang-(1-7) infusion exerted a direct neuroprotective action during l ischemic injury in the brain by reducing cell swelling and death. These effects were mediated by decreased NOX expression with the consequent reduction of ROS production.- The beneficial effect of Ang-(1-7)/MasR stimulation on cerebral ischemic injury showed a greater protective effect in older animals.- Neuroprotective effects of Ang-(1-7) were mediated by MasR. | Zheng et al., 2014 [128] | ||
Hemorrhagic stroke | Stroke-prone SHRs (spSHRs) | - ICV Ang-(1-7) infusion into spSHRs fed a high-sodium (4%) diet for 6 weeks decreased the number of hemorrhages in the striatum, enhanced neurological status, reduced the striatal microglia and increased survival.- Ang-(1-7) effects were partly prevented by ICV infusion of the MasR blocker, A-779. | Regenhardt et al., 2014 [127] |
Intracerebral hemorrhage | - ICV infusion of Ang-(1-7) enhanced neurological function compared with rats that received control solution. | Del Bigio et al., 1996 [129] |
COX-2: cyclooxygenase 2; eNOS: endothelial nitric oxide synthase; NOX: NADPH oxidase; ROS: Reactive oxygen species
NLRM wrote the first draft of the manuscript; AMP wrote sections of the manuscript; MMG conceived the idea, wrote sections of the manuscript and critically reviewed the manuscript. All authors contributed to manuscript revision, read and approved the submitted version.
The authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2021.